Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PDEX Pro Dex Inc
- Stocks
- Healthcare
- NASDAQ: PDEX
Price (delayed)
$43.38
Market cap
$141.46M
P/E Ratio
15.22
Dividend/share
N/A
EPS
$2.85
Enterprise value
$156.09M
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. It
Highlights
Pro Dex's gross profit has increased by 45% YoY and by 10% from the previous quarter
Pro Dex's EPS has increased by 40% QoQ
The quick ratio has declined by 28% year-on-year but it is up by 4.4% since the previous quarter
Pro Dex's debt has increased by 46% YoY and by 10% QoQ
Key stats
What are the main financial stats of PDEX
Market
Valuations
Earnings
Shares outstanding
3.26M
Market cap
$141.46M
Enterprise value
$156.09M
Price to earnings (P/E)
15.22
Price to book (P/B)
4.01
Price to sales (P/S)
2.21
EV/EBIT
11.88
EV/EBITDA
10.86
EV/Sales
2.43
Revenue
$64.12M
Gross profit
$20.11M
Operating income
$11.7M
Net income
$9.37M
EBIT
$13.14M
EBITDA
$14.37M
Free cash flow
-$1.75M
Per share
Balance sheet
Liquidity
EPS
$2.85
EPS diluted
$2.79
Free cash flow per share
-$0.54
Book value per share
$10.82
Revenue per share
$19.66
TBVPS
$19.7
Total assets
$64.27M
Total liabilities
$28.99M
Debt
$19.1M
Equity
$35.28M
Working capital
$31.63M
Debt to equity
0.54
Current ratio
2.73
Quick ratio
1.41
Net debt/EBITDA
1.02
Margins
Efficiency
Dividend
EBITDA margin
22.4%
Gross margin
31.4%
Net margin
14.6%
Operating margin
18.2%
Return on assets
16.2%
Return on equity
29.1%
Return on invested capital
23.3%
Return on capital employed
28.6%
Return on sales
20.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PDEX stock price
How has the Pro Dex stock price performed over time
Intraday
1.56%
1 week
-35.54%
1 month
-21.08%
1 year
131.98%
YTD
-7.21%
QTD
-12.51%
Financial performance
How have Pro Dex's revenue and profit performed over time
Revenue
$64.12M
Gross profit
$20.11M
Operating income
$11.7M
Net income
$9.37M
Gross margin
31.4%
Net margin
14.6%
PDEX's operating income has surged by 82% year-on-year and by 14% since the previous quarter
Pro Dex's gross profit has increased by 45% YoY and by 10% from the previous quarter
PDEX's operating margin is up by 40% YoY and by 8% QoQ
PDEX's net income is up by 39% since the previous quarter
Price vs fundamentals
How does PDEX's price correlate with its fundamentals
Growth
What is Pro Dex's growth rate over time
Valuation
What is Pro Dex stock price valuation
P/E
15.22
P/B
4.01
P/S
2.21
EV/EBIT
11.88
EV/EBITDA
10.86
EV/Sales
2.43
Pro Dex's EPS has increased by 40% QoQ
PDEX's P/E is 34% below its last 4 quarters average of 22.9 and 9% below its 5-year quarterly average of 16.7
PDEX's price to book (P/B) is 18% higher than its 5-year quarterly average of 3.4 and 8% higher than its last 4 quarters average of 3.7
PDEX's equity is up by 14% year-on-year and by 11% since the previous quarter
PDEX's revenue is up by 30% YoY and by 5% QoQ
The stock's price to sales (P/S) is 16% more than its 5-year quarterly average of 1.9 and 11% more than its last 4 quarters average of 2.0
Efficiency
How efficient is Pro Dex business performance
The return on equity has increased by 34% since the previous quarter
Pro Dex's return on sales has increased by 33% QoQ
Pro Dex's ROIC has increased by 33% from the previous quarter
Pro Dex's return on assets has increased by 31% QoQ
Dividends
What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PDEX.
Financial health
How did Pro Dex financials performed over time
The total assets is 122% greater than the total liabilities
PDEX's total liabilities is up by 48% YoY
The quick ratio has declined by 28% year-on-year but it is up by 4.4% since the previous quarter
Pro Dex's debt is 46% lower than its equity
Pro Dex's debt has increased by 46% YoY and by 10% QoQ
Pro Dex's debt to equity has increased by 29% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.